New Clinical Trials for Vaccines
The subject matter for vaccine clinical research is almost endless. There are so many diseases and chronic ailments that it would be wonderful to have a vaccine for all of them. Unfortunately that’s not realistic.
Costs are a prohibitive factor in the study, development and widespread use of a vaccine. There are ongoing vaccine clinical studies to test those that might be good possibilities. Please review the list of current vaccine clinical trials and let us know if you think you qualify.
What are Vaccines?
Vaccines are biological preparations that can help build immunity to diseases when given in small amounts. The way a vaccine works is that the body’s immune system attacks the foreign body found in the vaccine. The next time that body shows up the immune system “remembers” it and knows how to deal with it.
There are two types of vaccines – prophylactic which prevent, and therapeutic which is used against things like cancer. Vaccines were first recognized and studied in the 1770s with smallpox. Vaccines are usually made up of dead versions of a disease, although in some cases living versions are used. There is some controversy surrounding vaccine treatments. Some groups believe that they do not work.
Vaccine Treatments
Sometimes the immune system simply does not respond to vaccines. With the development of many different vaccines children these days are on a complicated schedule of vaccines shots and booster shots starting once their immune systems have fully developed. Mild forms of the disease may develop after a vaccine treatment.
A needle is the most common method of giving vaccines, but new methods for administering them are being developed. These include pills, patches and inhalers. An example of a successful vaccine treatment is the measles. In 1958 there were 763,094 cases. In 2008, after a measles vaccine was developed, there were only 54 cases.
We've found
87 Vaccines
clinical trials
Meningococcal Vaccine Clinical Trial
A Trial to Describe the Immunogenicity and Safety of 2 Doses of Bivalent rLP2086 (Trumenba) and a Pentavalent Meningococcal Vaccine in Healthy Subjects >=10 to
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Click here to add this to my saved trials
Click here to add this to my saved trials
Click here to add this to my saved trials
Immunology / Infectious Diseases, Oncology Clinical Trial
Clinical Outcomes of the Endoscopic Resection of Premalignant and Malignant Gastrointestinal Lesions
Status: Enrolling,
Phase
Updated: 12/31/1969
Click here to add this to my saved trials
Meningococcal Vaccine Clinical Trial
A Trial to Describe the Immunogenicity and Safety of 2 Doses of Bivalent rLP2086 (Trumenba) and a Pentavalent Meningococcal Vaccine in Healthy Subjects >=10 to
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Meningococcal Vaccine Clinical Trial
A Trial to Describe the Immunogenicity and Safety of 2 Doses of Bivalent rLP2086 (Trumenba) and a Pentavalent Meningococcal Vaccine in Healthy Subjects >=10 to
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Meningococcal Vaccine Clinical Trial
A Trial to Describe the Immunogenicity and Safety of 2 Doses of Bivalent rLP2086 (Trumenba) and a Pentavalent Meningococcal Vaccine in Healthy Subjects >=10 to
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Meningococcal Vaccine Clinical Trial
A Trial to Describe the Immunogenicity and Safety of 2 Doses of Bivalent rLP2086 (Trumenba) and a Pentavalent Meningococcal Vaccine in Healthy Subjects >=10 to
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Meningococcal Vaccine Clinical Trial
A Trial to Describe the Immunogenicity and Safety of 2 Doses of Bivalent rLP2086 (Trumenba) and a Pentavalent Meningococcal Vaccine in Healthy Subjects >=10 to
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Meningococcal Vaccine Clinical Trial
A Trial to Describe the Immunogenicity and Safety of 2 Doses of Bivalent rLP2086 (Trumenba) and a Pentavalent Meningococcal Vaccine in Healthy Subjects >=10 to
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Meningococcal Vaccine Clinical Trial
A Trial to Describe the Immunogenicity and Safety of 2 Doses of Bivalent rLP2086 (Trumenba) and a Pentavalent Meningococcal Vaccine in Healthy Subjects >=10 to
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Meningococcal Vaccine Clinical Trial
A Trial to Describe the Immunogenicity and Safety of 2 Doses of Bivalent rLP2086 (Trumenba) and a Pentavalent Meningococcal Vaccine in Healthy Subjects >=10 to
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
HPV Vaccines Clinical Trial
Increasing HPV Vaccination in Community-Based Pediatric Practices
Status: Enrolling
Updated: 2/1/2018
Click here to add this to my saved trials
Gastroenterology, Immunology / Infectious Diseases Clinical Trial
Los Angeles Prospective GI Biliary and EUS Series
Status: Enrolling
Updated: 4/13/2016
Click here to add this to my saved trials
Immunology / Infectious Diseases Clinical Trial
Microneedle Patch Study in Healthy Infants/Young Children
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Meningococcal Vaccine Clinical Trial
A Trial to Describe the Immunogenicity and Safety of 2 Doses of Bivalent rLP2086 (Trumenba) and a Pentavalent Meningococcal Vaccine in Healthy Subjects >=10 to
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Meningococcal Vaccine Clinical Trial
A Trial to Describe the Immunogenicity and Safety of 2 Doses of Bivalent rLP2086 (Trumenba) and a Pentavalent Meningococcal Vaccine in Healthy Subjects >=10 to
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Meningococcal Vaccine Clinical Trial
A Trial to Describe the Immunogenicity and Safety of 2 Doses of Bivalent rLP2086 (Trumenba) and a Pentavalent Meningococcal Vaccine in Healthy Subjects >=10 to
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Meningococcal Vaccine Clinical Trial
A Trial to Describe the Immunogenicity and Safety of 2 Doses of Bivalent rLP2086 (Trumenba) and a Pentavalent Meningococcal Vaccine in Healthy Subjects >=10 to
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Meningococcal Vaccine Clinical Trial
A Trial to Describe the Immunogenicity and Safety of 2 Doses of Bivalent rLP2086 (Trumenba) and a Pentavalent Meningococcal Vaccine in Healthy Subjects >=10 to
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Meningococcal Vaccine Clinical Trial
A Trial to Describe the Immunogenicity and Safety of 2 Doses of Bivalent rLP2086 (Trumenba) and a Pentavalent Meningococcal Vaccine in Healthy Subjects >=10 to
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Meningococcal Vaccine Clinical Trial
A Trial to Describe the Immunogenicity and Safety of 2 Doses of Bivalent rLP2086 (Trumenba) and a Pentavalent Meningococcal Vaccine in Healthy Subjects >=10 to
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Meningococcal Vaccine Clinical Trial
A Trial to Describe the Immunogenicity and Safety of 2 Doses of Bivalent rLP2086 (Trumenba) and a Pentavalent Meningococcal Vaccine in Healthy Subjects >=10 to
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Immunology / Infectious Diseases Clinical Trial
Flu2Text: Text Message Reminders for 2nd Dose of Influenza Vaccine
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Immunology / Infectious Diseases Clinical Trial
Centralized IIS-based Reminder/Recall to Increase Childhood Influenza Vaccination Rates_2nd Trial in Colorado
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Immunology / Infectious Diseases, Oncology Clinical Trial
A Study of RGX-202-01 With or Without FOLFIRI in Patients With Advanced Gastrointestinal Malignancies
Status: Enrolling,
Phase
I
Updated: 12/31/1969
Click here to add this to my saved trials
Gastrointestinal Neoplasms Clinical Trial
Crossover Trial of Systemic Chemotherapy in Patients With Metastatic Well-Differentiated Mucinous Appendiceal Adenocarcinomas With Pseudomyxoma Peritonei
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Meningococcal Vaccine Clinical Trial
A Trial to Describe the Immunogenicity and Safety of 2 Doses of Bivalent rLP2086 (Trumenba) and a Pentavalent Meningococcal Vaccine in Healthy Subjects >=10 to
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Meningococcal Vaccine Clinical Trial
A Trial to Describe the Immunogenicity and Safety of 2 Doses of Bivalent rLP2086 (Trumenba) and a Pentavalent Meningococcal Vaccine in Healthy Subjects >=10 to
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Meningococcal Vaccine Clinical Trial
A Trial to Describe the Immunogenicity and Safety of 2 Doses of Bivalent rLP2086 (Trumenba) and a Pentavalent Meningococcal Vaccine in Healthy Subjects >=10 to
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Meningococcal Vaccine Clinical Trial
A Trial to Describe the Immunogenicity and Safety of 2 Doses of Bivalent rLP2086 (Trumenba) and a Pentavalent Meningococcal Vaccine in Healthy Subjects >=10 to
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Meningococcal Vaccine Clinical Trial
A Trial to Describe the Immunogenicity and Safety of 2 Doses of Bivalent rLP2086 (Trumenba) and a Pentavalent Meningococcal Vaccine in Healthy Subjects >=10 to
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Meningococcal Vaccine Clinical Trial
A Trial to Describe the Immunogenicity and Safety of 2 Doses of Bivalent rLP2086 (Trumenba) and a Pentavalent Meningococcal Vaccine in Healthy Subjects >=10 to
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Immunology / Infectious Diseases, Oncology Clinical Trial
Acquisition of Blood and Tumor Tissue Samples From Patients With Gastrointestinal Cancer
Status: Enrolling,
Phase
Updated: 12/31/1969
Click here to add this to my saved trials
Meningococcal Vaccine Clinical Trial
A Trial to Describe the Immunogenicity and Safety of 2 Doses of Bivalent rLP2086 (Trumenba) and a Pentavalent Meningococcal Vaccine in Healthy Subjects >=10 to
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Meningococcal Vaccine Clinical Trial
A Trial to Describe the Immunogenicity and Safety of 2 Doses of Bivalent rLP2086 (Trumenba) and a Pentavalent Meningococcal Vaccine in Healthy Subjects >=10 to
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Meningococcal Vaccine Clinical Trial
A Trial to Describe the Immunogenicity and Safety of 2 Doses of Bivalent rLP2086 (Trumenba) and a Pentavalent Meningococcal Vaccine in Healthy Subjects >=10 to
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Meningococcal Vaccine Clinical Trial
A Trial to Describe the Immunogenicity and Safety of 2 Doses of Bivalent rLP2086 (Trumenba) and a Pentavalent Meningococcal Vaccine in Healthy Subjects >=10 to
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Meningococcal Vaccine Clinical Trial
A Trial to Describe the Immunogenicity and Safety of 2 Doses of Bivalent rLP2086 (Trumenba) and a Pentavalent Meningococcal Vaccine in Healthy Subjects >=10 to
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Meningococcal Vaccine Clinical Trial
A Trial to Describe the Immunogenicity and Safety of 2 Doses of Bivalent rLP2086 (Trumenba) and a Pentavalent Meningococcal Vaccine in Healthy Subjects >=10 to
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Meningococcal Vaccine Clinical Trial
A Trial to Describe the Immunogenicity and Safety of 2 Doses of Bivalent rLP2086 (Trumenba) and a Pentavalent Meningococcal Vaccine in Healthy Subjects >=10 to
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Meningococcal Vaccine Clinical Trial
A Trial to Describe the Immunogenicity and Safety of 2 Doses of Bivalent rLP2086 (Trumenba) and a Pentavalent Meningococcal Vaccine in Healthy Subjects >=10 to
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Meningococcal Vaccine Clinical Trial
A Trial to Describe the Immunogenicity and Safety of 2 Doses of Bivalent rLP2086 (Trumenba) and a Pentavalent Meningococcal Vaccine in Healthy Subjects >=10 to
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Meningococcal Vaccine Clinical Trial
A Trial to Describe the Immunogenicity and Safety of 2 Doses of Bivalent rLP2086 (Trumenba) and a Pentavalent Meningococcal Vaccine in Healthy Subjects >=10 to
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Immunology / Infectious Diseases, Oncology Clinical Trial
A Study of RGX-202-01 With or Without FOLFIRI in Patients With Advanced Gastrointestinal Malignancies
Status: Enrolling,
Phase
I
Updated: 12/31/1969
Click here to add this to my saved trials
Immunology / Infectious Diseases, Oncology Clinical Trial
A Study of RGX-202-01 With or Without FOLFIRI in Patients With Advanced Gastrointestinal Malignancies
Status: Enrolling,
Phase
I
Updated: 12/31/1969
Click here to add this to my saved trials
Vaccine Clinical Trial
Follow-Up Study of Subjects Previously Enrolled in Poxviral Vector Gene Transfer Studies
Status: Enrolling,
Phase
Updated: 12/31/1969
Click here to add this to my saved trials
Yellow Fever Vaccine Clinical Trial
Immune Responses to Yellow Fever Vaccine
Status: Enrolling,
Phase
Updated: 12/31/1969
Click here to add this to my saved trials
Gastroenterology, Immunology / Infectious Diseases, Oncology Clinical Trial
Mithramycin for Lung, Esophagus, and Other Chest Cancers
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Meningococcal Vaccine Clinical Trial
A Trial to Describe the Immunogenicity and Safety of 2 Doses of Bivalent rLP2086 (Trumenba) and a Pentavalent Meningococcal Vaccine in Healthy Subjects >=10 to
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Meningococcal Vaccine Clinical Trial
A Trial to Describe the Immunogenicity and Safety of 2 Doses of Bivalent rLP2086 (Trumenba) and a Pentavalent Meningococcal Vaccine in Healthy Subjects >=10 to
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Meningococcal Vaccine Clinical Trial
A Trial to Describe the Immunogenicity and Safety of 2 Doses of Bivalent rLP2086 (Trumenba) and a Pentavalent Meningococcal Vaccine in Healthy Subjects >=10 to
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Meningococcal Vaccine Clinical Trial
A Trial to Describe the Immunogenicity and Safety of 2 Doses of Bivalent rLP2086 (Trumenba) and a Pentavalent Meningococcal Vaccine in Healthy Subjects >=10 to
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Meningococcal Vaccine Clinical Trial
A Trial to Describe the Immunogenicity and Safety of 2 Doses of Bivalent rLP2086 (Trumenba) and a Pentavalent Meningococcal Vaccine in Healthy Subjects >=10 to
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Meningococcal Vaccine Clinical Trial
A Trial to Describe the Immunogenicity and Safety of 2 Doses of Bivalent rLP2086 (Trumenba) and a Pentavalent Meningococcal Vaccine in Healthy Subjects >=10 to
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Meningococcal Vaccine Clinical Trial
A Trial to Describe the Immunogenicity and Safety of 2 Doses of Bivalent rLP2086 (Trumenba) and a Pentavalent Meningococcal Vaccine in Healthy Subjects >=10 to
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Meningococcal Vaccine Clinical Trial
A Trial to Describe the Immunogenicity and Safety of 2 Doses of Bivalent rLP2086 (Trumenba) and a Pentavalent Meningococcal Vaccine in Healthy Subjects >=10 to
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Meningococcal Vaccine Clinical Trial
A Trial to Describe the Immunogenicity and Safety of 2 Doses of Bivalent rLP2086 (Trumenba) and a Pentavalent Meningococcal Vaccine in Healthy Subjects >=10 to
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Meningococcal Vaccine Clinical Trial
A Trial to Describe the Immunogenicity and Safety of 2 Doses of Bivalent rLP2086 (Trumenba) and a Pentavalent Meningococcal Vaccine in Healthy Subjects >=10 to
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Meningococcal Vaccine Clinical Trial
A Trial to Describe the Immunogenicity and Safety of 2 Doses of Bivalent rLP2086 (Trumenba) and a Pentavalent Meningococcal Vaccine in Healthy Subjects >=10 to
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Meningococcal Vaccine Clinical Trial
A Trial to Describe the Immunogenicity and Safety of 2 Doses of Bivalent rLP2086 (Trumenba) and a Pentavalent Meningococcal Vaccine in Healthy Subjects >=10 to
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Meningococcal Vaccine Clinical Trial
A Trial to Describe the Immunogenicity and Safety of 2 Doses of Bivalent rLP2086 (Trumenba) and a Pentavalent Meningococcal Vaccine in Healthy Subjects >=10 to
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Meningococcal Vaccine Clinical Trial
A Trial to Describe the Immunogenicity and Safety of 2 Doses of Bivalent rLP2086 (Trumenba) and a Pentavalent Meningococcal Vaccine in Healthy Subjects >=10 to
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Immunology / Infectious Diseases Clinical Trial
Flu2Text: Text Message Reminders for 2nd Dose of Influenza Vaccine
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Immunology / Infectious Diseases, Oncology Clinical Trial
A Study of RGX-202-01 With or Without FOLFIRI in Patients With Advanced Gastrointestinal Malignancies
Status: Enrolling,
Phase
I
Updated: 12/31/1969
Click here to add this to my saved trials
Immunology / Infectious Diseases, Oncology Clinical Trial
A Study of RGX-202-01 With or Without FOLFIRI in Patients With Advanced Gastrointestinal Malignancies
Status: Enrolling,
Phase
I
Updated: 12/31/1969
Click here to add this to my saved trials
Immunology / Infectious Diseases Clinical Trial
HPV Message Testing and Social Media Campaign
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Click here to add this to my saved trials
Vaccination Clinical Trial
Synchronized Immunization NotifiCations
Status: Upcoming
Updated: 3/21/2017
Click here to add this to my saved trials
Click here to add this to my saved trials
Gastroenterology, Immunology / Infectious Diseases, Oncology, Reproductive Clinical Trial
Trial of Linaclotide to Demonstrate Colorectal Bioactivity in Health Volunteers
Status: Upcoming
Updated: 7/29/2013
Click here to add this to my saved trials
Immunology / Infectious Diseases Clinical Trial
Phase 1 Study of the Safety and Immunogenicity of a Malaria Transmission-blocking Pfs25-Pfs25 Conjugate Vaccine
Status: Upcoming
Updated: 10/5/2012
Click here to add this to my saved trials
Vaccination Clinical Trial
Synchronized Immunization NotifiCations
Status: Upcoming
Updated: 3/21/2017
Click here to add this to my saved trials
Meningococcal Vaccine Clinical Trial
A Trial to Describe the Immunogenicity and Safety of 2 Doses of Bivalent rLP2086 (Trumenba) and a Pentavalent Meningococcal Vaccine in Healthy Subjects >=10 to
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Meningococcal Vaccine Clinical Trial
A Trial to Describe the Immunogenicity and Safety of 2 Doses of Bivalent rLP2086 (Trumenba) and a Pentavalent Meningococcal Vaccine in Healthy Subjects >=10 to
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Immunology / Infectious Diseases Clinical Trial
The STOP-HPV Trial 3: Prompts Intervention
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Meningococcal Vaccine Clinical Trial
A Trial to Describe the Immunogenicity and Safety of 2 Doses of Bivalent rLP2086 (Trumenba) and a Pentavalent Meningococcal Vaccine in Healthy Subjects >=10 to
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Immunology / Infectious Diseases, Oncology Clinical Trial
A Study of RGX-202-01 With or Without FOLFIRI in Patients With Advanced Gastrointestinal Malignancies
Status: Enrolling,
Phase
I
Updated: 12/31/1969
Click here to add this to my saved trials
Immunology / Infectious Diseases Clinical Trial
The STOP-HPV Trial 6: Single Arm Evaluation of the Maintenance of the STOP-HPV Bundle
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Meningococcal Vaccine Clinical Trial
A Trial to Describe the Immunogenicity and Safety of 2 Doses of Bivalent rLP2086 (Trumenba) and a Pentavalent Meningococcal Vaccine in Healthy Subjects >=10 to
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Immunology / Infectious Diseases Clinical Trial
The STOP-HPV Trial 2: Performance Feedback Intervention
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Meningococcal Vaccine Clinical Trial
A Trial to Describe the Immunogenicity and Safety of 2 Doses of Bivalent rLP2086 (Trumenba) and a Pentavalent Meningococcal Vaccine in Healthy Subjects >=10 to
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Immunology / Infectious Diseases Clinical Trial
Flu2Text: Text Message Reminders for 2nd Dose of Influenza Vaccine
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Immunology / Infectious Diseases Clinical Trial
The STOP-HPV Trial 5: Single Arm Evaluation of the Bundle
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Immunology / Infectious Diseases Clinical Trial
The STOP-HPV Trial 1: Communication Intervention
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Immunology / Infectious Diseases Clinical Trial
The STOP-HPV Trial 4: Bundle Intervention
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Updated: 12/31/1969
Updated: 12/31/1969
Updated: 12/31/1969
Updated: 12/31/1969
Updated: 12/31/1969
Updated: 12/31/1969
Updated: 12/31/1969
Updated: 12/31/1969
Updated: 12/31/1969
Updated: 12/31/1969
Updated: 2/1/2018
Updated: 4/13/2016
Updated: 12/31/1969
Updated: 12/31/1969
Updated: 12/31/1969
Updated: 12/31/1969
Updated: 12/31/1969
Updated: 12/31/1969
Updated: 12/31/1969
Updated: 12/31/1969
Updated: 12/31/1969
Updated: 12/31/1969
Updated: 12/31/1969
Updated: 12/31/1969
Updated: 12/31/1969
Updated: 12/31/1969
Updated: 12/31/1969
Updated: 12/31/1969
Updated: 12/31/1969
Updated: 12/31/1969
Updated: 12/31/1969
Updated: 12/31/1969
Updated: 12/31/1969
Updated: 12/31/1969
Updated: 12/31/1969
Updated: 12/31/1969
Updated: 12/31/1969
Updated: 12/31/1969
Updated: 12/31/1969
Updated: 12/31/1969
Updated: 12/31/1969
Updated: 12/31/1969
Updated: 12/31/1969
Updated: 12/31/1969
Updated: 12/31/1969
Updated: 12/31/1969
Updated: 12/31/1969
Updated: 12/31/1969
Updated: 12/31/1969
Updated: 12/31/1969
Updated: 12/31/1969
Updated: 12/31/1969
Updated: 12/31/1969
Updated: 12/31/1969
Updated: 12/31/1969
Updated: 12/31/1969
Updated: 12/31/1969
Updated: 12/31/1969
Updated: 12/31/1969
Updated: 12/31/1969
Updated: 12/31/1969
Updated: 12/31/1969
Updated: 12/31/1969
Updated: 12/31/1969
Updated: 12/31/1969
Updated: 3/21/2017
Updated: 7/29/2013
Updated: 10/5/2012
Updated: 3/21/2017
Updated: 12/31/1969
Updated: 12/31/1969
Updated: 12/31/1969
Updated: 12/31/1969
Updated: 12/31/1969
Updated: 12/31/1969
Updated: 12/31/1969
Updated: 12/31/1969
Updated: 12/31/1969
Updated: 12/31/1969
Updated: 12/31/1969
Updated: 12/31/1969
Updated: 12/31/1969